You know, it’s not everyday a fellow like me gets to
announce a major paradigm shift, much less concerning diabetes
…or any other medical condition.
You don’t know what a paradigm shift is? Well, if I
mentioned events and names like: Gutenberg, Copernicus, Isaac
Newton, Albert Einstein, Louis Pasteur, and Werner von Braun
…you would probably guess a paradigm shift is major shift in
thinking…and you would be right.
Back in the 1960’s, Thomas Kuhn wrote a famous book, The
Structure of Scientific Revolutions. In it, he destroyed the
common misconception so many of us have about science.
We tend to think scientific progress is ushered in by a
slow, line upon line, piece by piece development of thought
over time.
Thomas Kuhn showed that, historically, scientific progress
occurs in leaps …and is always confronted by a struggle with
an “old guard.” The old scientific theorists hold tenaciously
to their (usually tenured or profitable) positions and array
themselves against the new discovery, attempting to drive it
away.
But, the new guard – the new discoverers, inventors,
explorers– takes the new discoveries and advances it over the
thinking of the old establishment. Rarely is the old guard
converted to the new patterns of thinking (new discovery).
They just die off. The new position wins by attrition
…truth…and perseverance.
Diabetes: The $132 billion dollar pandemic
Diabetes is on the front edge of such a paradigm shift.
Diabetes afflicts over 18 million Americans. That is double
the number of people with diabetes just since 1991 alone.
According to the CDC, one in every three Americans will
develop diabetes in their life*time. Let that sink in…one in
every three Americans will develop diabetes in their
life*time.
It is estimated over 40 million Americans can be classified
as “pre-diabetes” meaning they have blood sugar levels higher
than normal but still below the type 2 diagnosis level which
helps to define diabetes.
By anyone’s standard that is pandemic (goes far beyond
epidemic proportions). The cost for this carnage is over $132
BILLION DOLLARS. So much expense, grief and sorrow…and
unnecessary.
Diabetes: A reflection of our culture.
We are a fast food, sedentary, “get-our-fix-now”
generation. More than one in every two Americans are
overweight. We don’t exercise as we should. All of which
affects glucose levels. Diabetes is a lifestyle disease…and
we’ve got the lifestyle.
Diabetes: The important announcement
That said, diabetes is a condition which CAN be turned
around. Glyconutrition is the new discovery shaking the
medical and scientific worlds. There are four Nobel Prizes and
MIT testifying to the fact that glycobiology is one of the 10
technologies/discoveries which will shape our world.
Glyconutrition is more than just a promising new treatment
for diabetes. Many are starting to whisper “VICTORY” over
diabetes in their approach to disease.
Whether that is the case, time will tell.
Oh no… The problem is not a failure of glyconutrition. It
is the building block VITAL to healthy cell*ular function and
it is extremely vital to the proper functioning of the IMMUNE
system. Those are known facts.
Diabetes is an auto-immune disease meaning, your body’s
immune system gets misguided messages. Thus, it starts
attacking the islet cells in the pancreas which produces
insulin. Voila...diabetes!
But, the problem is NOT whether glyconutrition really
works. Anecdotal evidence (market buzz!) is already
overwhelming in favor of glyconutritional therapy for
diabetes. As is the professional research.
No…the actual science is NOT the problem. The problem is
the old guard again. Thomas Kuhn’s book is almost prophetic.
The old guard, the medical and pharmaceutical establishment,
just can’t accept the findings of (their own) research… “What!
A nutrient… to treat diabetes?” “Hogwash,” one can almost hear
them say.
Actually, I wish they were saying that out loud. The
reality is, they just ignore the issue. You see, too much is
at stake. Like billions of dollars…uh…a $132 billion dollars.
All of that mon*ey (read, “business”) disappears if
glyconutrition continues to “pan out” the way the research
shows us. But, for no^w, the only thing “panning out” is a
diabetes pandemic.
Yet, glyconutrition gets shunned as an official diabetes
treatment approach.
A study published in the 1997 issue of the Proceedings of
the Fisher Institute for Medical Research showed that people
with type 1 diabetes who were given glyconutrients “…reported
a dramatic improvement in their health, including a decrease
in vision problems, better wound healing, less infections, and
lower blood pressure.” (Miracle Sugars, by Rita Elkins, M.H.,
Woodland Publishing, p. 26)
“Glycobiology has achieved critical breakthroughs in the
medical field, primarily by addressing what could be the
greatest plague in health care today -- auto-immune diseases.
Multiple sclerosis, arthritis, diabetes, Crohn’s disease and
colitis are just a few of these diseases.” - Dr. Neecie Moore,
Ph.D. (cf. Rita Elkins, M.H.
Miracle Sugars, Woodland Publishing, p. 18.)
Also, mannose (one glyconutrient) can stimulate the
pancreas to produce more insulin “…thus lowering the amount of
insulin needed to control this disease.” (Miracle Sugars, p.
27).
Reality Check: The lives of 1 out of every 3 Americans are
affected directly by diabetes and there is a $132 billion
dollar diabetes pandemic running amuck in our midst. So, I
sure hope this paradigm shift - glyconutrition - gets less
opposition from the “powers that be” (the “old guard”), and is
given its rightful place in the sun…soon.
But, with the mon^ey being made by the pharmaceuticals and
their drugs, and the astoundingly simplistic view of disease
treatment (“Blast that disease with technology and drugs!”) it
is doubtful if Thomas Kuhn’s “paradigm shift” will work out
any differently for diabetes across the land.
The old guard will attack and ignore the discovery —
arguably, the greatest in medical history in over a hundred
years — and, a la Kuhn, they will simply go the way of the
Dodo Bird and diabetes treatment will receive its due.
|
About The Author
Dr. Robert Gamble is retired from a very successful
medical/surgical career. His articles are designed to
encourage people about the exciting discoveries
surrounding glyconutrition. Visit www.glycoshare.com or write sharethegift@glycoshare.com or…
call toll free: 1866.735.5871
|
